Skip to main content
. 2022 Jun 6;27(8):3214–3222. doi: 10.1038/s41380-022-01638-z

Fig. 4. Prevalence of general public’s and health worker’s depression, anxiety, and insomnia during pandemics across countries.

Fig. 4

General public: (a) depression, range: 12.5% (Israel)–66.7% (Jordan); (b) anxiety, range: 23.9% (Saudi Arabia)–71.0% (United Arab Emirates); (c) insomnia, range: 23.2% (China)–56.0% (USA); (d) moderate-to-severe depression, range: 3.5% (India)–36.3% (Australia); (e) moderate-to-severe anxiety, range: 10.9% (Japan)–72.1% (Malaysia); (f) moderate-to-severe insomnia, range: 5.7% (China)–42.0% (Columbia); Health worker: (g) depression, range: 22.5% (India)–78.0% (Jordan); (h) anxiety, range: 17.1% (India)–95.5% (Pakistan); (i) insomnia, range: 18.5% (Oman)–75.2% (Bahrain); (j) moderate-to-severe depression, range: 5.3% (Spain)–47.1% (Turkey); (k) moderate-to-severe anxiety, range: 1.5% (India)–53.5% (Pakistan); (l) moderate-to-severe insomnia, range: 8.3% (Italy)–24.4% (China).